Networking Roundtables return to this year’s Best of ASTRO
The 2019 Best of ASTRO takes place November 15-16 at The Ritz-Carlton, Washington, D.C. If you missed the recent successful Annual Meeting in Chicago, this is a great opportunity to get a summary of the most relevant science presented in a compact, two-day format. Experts present the science by disease site, with a focus on what’s new and how it will affect daily practice. Returning this year for both days are the popular, lunchtime networking sessions with disease-site table topics led by a faculty member. You’ll have the chance to ask questions, discuss current topics and network with your colleagues. View the full schedule of events and register by October 23 to take advantage of the advance rates.
Presentations for patients, caregivers, and health care professionals available for download, customization
Are you looking for a way to introduce radiation therapy to your patients and their caregivers or to other health care professionals? Two presentations are available for download and customization. A 24-slide presentation designed for patients, caregivers and the general public, introduces the practice and describes its uses, radiation oncology team members and their roles, processes and treatment planning, delivery of care and links to more information. A 36-slide presentation, designed for health care professionals, presents similar information to help your oncology colleagues become more familiar with the field. Download the presentations from the ASTRO website Patient Care and Research page and customize, if necessary, for your practice.
Did you miss the news from the 2019 Annual Meeting?
Get caught up on highlights and happenings from ASTRO’s 61st Annual Meeting. ASTRO’s Digital Daily News and Show Dailies offered in-depth coverage of key sessions including both Keynote addresses, Clinical Trials, Plenary and all six Science Highlights sessions, which covered top research from six disease sites. Read more at www.astro.org/ShowDailies.
Don’t forget! Claim your Annual Meeting Continuing Education credits
Annual Meeting attendees, don't forget to claim your Continuing Education credits by October 18. In order to claim credits or get your certificate of attendance, please evaluate at least one session and complete the Meeting Survey on the conference planner. Be sure to complete your claim by October 18, 2019.
Reminder to comment on ASTRO guideline on radiation for small cell lung cancer
Time is running out to provide feedback on the draft Radiation Therapy for Small Cell Lung Cancer: An ASTRO Clinical Practice Guideline. This guideline covers indications, dose-fractionation and timing of thoracic radiation in limited- and extensive-stage disease; the role of SBRT for stage I or II node negative tumors; and appropriate use of prophylactic cranial irradiation. It was developed by a multidisciplinary team of radiation, medical and thoracic oncologists, a radiation oncology resident and a patient representative. The deadline to provide your comments via our webform is Wednesday, October 9.
ASTRO seeks comments on HDR brachytherapy and brachytherapy of prostate cancer practice parameters
The public comment period (field review) for the Practice Parameters for the Performance of Radionuclide-based High-dose-rate Brachytherapy and Transperineal Permanent Brachytherapy of Prostate Cancer is now open. The deadline for submission is Wednesday, October 16. These practice parameters were collaboratively revised by the American College of Radiology (ACR), American Brachytherapy Society and ASTRO. The documents were reviewed by the ACR expert panels, which included radiation oncologists. To log your recommendations for these documents, please send them to Lisa Bradfield or contact her with any questions. Recommendations should propose specific language to amend the documents.
ASTRO seeks public comments on guideline recommendations for hereditary breast cancer
ASTRO requests feedback on the draft recommendations for the ASCO-ASTRO-SSO Management of Hereditary Breast Cancer guideline. The guideline focuses on patients with BRCA 1/2 or moderate-penetrance germline mutations and addresses the role of contralateral prophylactic mastectomy, adjuvant radiation therapy and breast conserving surgery with radiotherapy versus mastectomy. It also makes recommendations on the role of platinum systemic therapy and PARP inhibitors in this population for both early- and late-stage breast cancer. The comment period is October 3-17. To participate, interested reviewers can download the confidentiality agreement and email a signed copy to ASCO Guidelines to receive access to the survey containing the guideline recommendations.
Beware of fake ASTRO Meeting and Housing websites
It has come to our attention that one or more companies are claiming to be associated with ASTRO to assist attendees and exhibitors with registration and housing for the 2020 ASTRO Annual Meeting in Miami Beach. The only company affiliated with ASTRO to provide this service is SPARGO Inc. Attendee registration and housing for ASTRO 2020 will open in mid-June. The website to register and reserve housing is www.astro.org/AnnualMeeting. If you are contacted by anyone other than SPARGO Inc., please use caution in giving out any personal or financial information, and notify ASTRO Meetings staff to pass along any information or communications you receive.
Mission Cancer Program receives APEx accreditation
Congratulations to Mission Cancer Program, in Asheville, North Carolina, for recently completing the ASTRO Accreditation Program for Excellence (APEx®). To be fully accredited, a facility must meet a majority of the APEx standards in a satisfactory manner, and the accreditation status is valid for four years. View a list of accredited facilities, and contact ASTRO staff for additional information on the APEx program.